Discovery, Characterization, and Structure of a Cell Active PAD2 Inhibitor Acting through a Novel Allosteric Mechanism
Laura J. Byrnes,Won Young Choi,Paul Balbo,Mary Ellen Banker,Jeanne Chang,Shi Chen,Xuemin Cheng,Yang Cong,Jeff Culp,Hongxia Di,Matt Griffor,Justin Hall,Xiaoyun Meng,Barry Morgan,James J. Mousseau,Jennifer Nicki,Thomas O’Connell,Simeon Ramsey,Alex Shaginian,Suman Shanker,John Trujillo,Jinqiao Wan,Fabien Vincent,Stephen W. Wright,Felix Vajdos
DOI: https://doi.org/10.1021/acschembio.4c00397
IF: 4.634
2024-09-25
ACS Chemical Biology
Abstract:Peptidyl arginine deiminases (PADs) are important enzymes in many diseases, especially those involving inflammation and autoimmunity. Despite many years of effort, developing isoform-specific inhibitors has been a challenge. We describe herein the discovery of a potent, noncovalent PAD2 inhibitor, with selectivity over PAD3 and PAD4, from a DNA-encoded library. The biochemical and biophysical characterization of this inhibitor and two noninhibitory binders indicated a novel, Ca^(2+) competitive...
biochemistry & molecular biology